MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib

Adelaide I. J. Young, Andrew M. K. Law, Lesley Castillo, Sabrina Chong, Hayley D. Cullen, Martin Koehler, Sebastian Herzog, Tilman Brummer, Erinna F. Lee, Walter D. Fairlie, Morghan C. Lucas\, David Morghan C., David Herrmann, Amr Allam, Paul Timpson, D. Neil Watkins, Ewan K. A. Millar, Sandra A. O'Toole, David Gallego-Ortega, Christopher J. Ormandy

Research output: Contribution to journalArticlepeer-review

69 Citations (Scopus)
1 Downloads (Pure)
Original languageEnglish
Article number125
Number of pages15
JournalBreast Cancer Research
Volume18
Issue number1
DOIs
Publication statusPublished - 2016

Open Access - Access Right Statement

© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Cite this